Detalles de la búsqueda
1.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Lancet Oncol
; 25(3): 317-325, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342115
2.
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer.
BMC Health Serv Res
; 22(1): 1403, 2022 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36419005
3.
Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer.
Future Oncol
; 17(8): 931-941, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33207944
4.
Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer.
Future Oncol
; 17(29): 3819-3831, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34227400
5.
Healthcare resource utilization and cost among patients treated for early-stage triple-negative breast cancer.
Future Oncol
; 17(29): 3833-3841, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34254533
6.
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Oncologist
; 25(8): e1233-e1241, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32476162
7.
Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women.
Breast Cancer Res Treat
; 182(2): 247-258, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447595
8.
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Breast Cancer Res Treat
; 184(2): 265-275, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776290
9.
Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer.
Breast J
; 26(2): 112-119, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31531938
10.
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(3): 310-320, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523670
11.
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
Breast Cancer Res Treat
; 165(2): 329-341, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612225
12.
Use of Biomarkers and Multigene Assays in Breast Cancer.
J Natl Compr Canc Netw
; 15(5S): 676-678, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28515241
13.
Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer.
J Natl Compr Canc Netw
; 15(3): 284-287, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275030
14.
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(12): 1520-1541, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29223990
15.
NCCN Guidelines Insights: Antiemesis, Version 2.2017.
J Natl Compr Canc Netw
; 15(7): 883-893, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28687576
16.
NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
J Natl Compr Canc Netw
; 15(4): 433-451, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28404755
17.
Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancer.
Psychooncology
; 26(6): 755-762, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26790987
18.
Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.
Int J Colorectal Dis
; 32(8): 1179-1190, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28424871
19.
Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study.
Health Qual Life Outcomes
; 15(1): 160, 2017 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28806963
20.
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
Cancer
; 122(15): 2418-25, 2016 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27176138